All
|
Total
|
112600
|
44
|
91
|
210
|
1242071
|
Data type
|
Dichotomous
|
77237
|
50
|
102
|
243
|
1242071
|
|
Continuous
|
29902
|
33
|
62
|
142
|
18851
|
|
Mixed
|
5461
|
21
|
86
|
251
|
36511
|
Medical specialty
|
Cancer
|
6441
|
72
|
154
|
326
|
266064
|
|
Cardiovascular
|
10686
|
44
|
102
|
289
|
67800
|
|
Central nervous system/musculoskeletal
|
8299
|
43
|
80
|
149
|
9440
|
|
Digestive/endocr., nutritional and metabolic
|
15345
|
42
|
79
|
160
|
18819
|
|
Gynaecology, pregnancy and birth
|
20098
|
60
|
118
|
293
|
23697
|
|
Infectious diseases
|
4502
|
59
|
130
|
371
|
419748
|
|
Mental health and behavioural conditions
|
15218
|
36
|
63
|
165
|
9020
|
|
Pathological conditions, symptoms and signs
|
4448
|
40
|
61
|
115
|
2463
|
|
Respiratory diseases
|
13153
|
36
|
87
|
227
|
82892
|
|
Urogenital
|
5914
|
39
|
71
|
153
|
4912
|
|
Other
|
8496
|
44
|
90
|
198
|
1242071
|
Interventions
|
Pharm. vs. Control/Placebo
|
44156
|
41
|
90
|
222
|
58050
|
|
Pharm. vs. Pharm.
|
28018
|
48
|
99
|
222
|
25180
|
|
Pharm. vs. Non-Pharm.
|
2018
|
50
|
74
|
135
|
7711
|
|
Non-Pharm. vs. Control/Placebo
|
20892
|
41
|
92
|
229
|
1242071
|
|
Non-Pharm. vs. Non-Pharm.
|
17516
|
45
|
85
|
169
|
82892
|
Outcomes
|
Signs/symptoms reflecting continuation/end of condition
|
17621
|
42
|
83
|
197
|
359600
|
|
Adverse events
|
11898
|
49
|
100
|
242
|
82892
|
|
Infection/onset of new acute/chronic disease
|
11284
|
56
|
110
|
258
|
1242071
|
|
Biological markers
|
10578
|
35
|
64
|
147
|
266064
|
|
General physical health
|
8959
|
30
|
66
|
177
|
131271
|
|
Obstetric outcomes
|
7376
|
60
|
117
|
293
|
18453
|
|
All-cause mortality
|
8302
|
52
|
110
|
281
|
259627
|
|
Resource use/hospital stay/process
|
5454
|
50
|
98
|
200
|
419748
|
|
Cause-specific mortality/major morbidity event/composite (mortality or morbidity)
|
5413
|
69
|
165
|
449
|
266064
|
|
Other outcomes (semi-objective)1
|
10886
|
44
|
81
|
177
|
131271
|
|
Other outcomes (subjective)2
|
14490
|
38
|
71
|
162
|
359600
|